Novartis Investigative Site

Fall River, Massachusetts 02721

0 studies enrolling now · 4 studies all time

What they study most

Atherosclerosis, Chronic Obstructive Pulmonary Disease, Major Depressive Disorder, Neoplasms, Breast

Studies at this site

• A Placebo- and Paroxetine-controlled Study of the Efficacy, Safety and Tolerability of Agomelatine (25 or 50 mg) in the Treatment of Major Depressive Disorder (MDD) — Completed
• Cardiovascular Risk Reduction Study (Reduction in Recurrent Major CV Disease Events) — Completed
• EAP (Expanded Access Protocol) Of Lapatinib Combined With Capecitabine In Metastatic Breast Cancer — APPROVED_FOR_MARKETING
• NVA237 BID Versus Placebo Twelve-week Efficacy Study — Completed